Caution! You’re in edit mode.

Pack Ventures

Follow us
report_icon Report
overview_icon Overview team_icon Team briefcase_icon Portfolio

Reach out to Pack Ventures

Reply Rate

20%

Responds in

13 hours

About Pack Ventures

Investor type

VC firm

First check

$50k to $500k

Lead

Sometimes

Themes

mRNA
biomarkers
genomics
proteomics
therapeutic
life-science
CBD
transcriptomics
CGT
cell therapy
cannabis
collaboration tools
student founders
life sciences
IVD
medicines
psychedelic
metabolomics
graduate
life sciences tools
lifesciences
subscription
metabolites
therapeutics
SaaS
pharmaceuticals
pharma
protein
gene therapy
biopharma
software
university
psychedelics
recurring
productivity tools
drug
biotech
life science
drugs
in vitro diagnostics
student
bio
lifescience
+36
See less
See all

Funding Stages

1. Idea or Patent2. Prototype3. Early Revenue

Countries of investment

Flag of USA USA

Who we are

We are Pack Ventures - a preseed and seed fund backing research led-companies by leveraging the resources of a $11B research university for deal flow and company support. We source our startups on campus, from the 550k+ alumni and globally when the U.W. resources can drive the success of the startup.

Funding Requirements

We invest in A.I. companies from chips to robots and all of the software in between, as well as techbio companies building at the intersection of A.I. and bio, through Pack. The defining companies of the next generation will be research-led, and Pack has unique access to the #1 publicly funded research university—the University of Washington.

Value add

We deploy UW's $1.7B research engine — labs, clinical infra, talent, IP — into the best frontier founders anywhere, winning cap-table spots capital can't. We have 1200+ VC contacts that we leverage for follow on funding. We also tap into UW and the UW network for customers and talent.

Frequently Asked Questions

5-10%
We typically engage in deep technical diligence. Robust customer diligence, and reference checks. We have a network of ~200 LPs that are executives, former founders and phds that we use as experts. Additionally we have access to 3000+ principle investigators (professors, and lab leaders) from across the university of Washington that are award winning scientists and researchers to support technical diligence. Our experience and networks at Amazon, Google and Microsoft, give us deep insights from large tech.
2 weeks, we have moved in days, but have also worked on Builds to create new companies over 18-24 months (before those inventors even consider themselves founders) while their research reaches commercial readiness. We meet many founders inside their labs and through commercialization programs that help develop companies, on campus at UW and from the top programs globally.
Quarterly financial reports including revenue, burn, new customers, hiring and other traction metrics is the minimum we require, but often our founders want weekly, bi-weekly, or monthly check-ins with one of our partners.
Most often observed seats to keep our information access high, but our time commitments reasonable for a fund with 25-50 companies per portfolio. We have one official director seat at this time.
We reserve about 10% of fund capital for following and support, and instead have a very efficient and structured sidecar program to offer our LPs access to our winners. LPs who invest $500k or less into the fund pay 0% mgmt fee/20% carry on sidecars Under $1m pay 0% mgmt fee/10% carry Fund LP commitments of $1M+ pay 0%/0% on side cars. All LPs get our diligence, the pitch deck and a recorded lunch and learn of the founder pitching and Q&A.
Yes, but rarely
Every investment needs the potential to return the entire fund with one check. With 2.5% ownership at exit, a company must surpass $2B when we exit to pay the entire fund. Additionally we expect regular updates so we can make informed decisions on when to exit or offer sidecar investments to LPs with our updated information asymmetry vs other investors. A successful investment must also balance our risk, diversity and exposure across the entire portfolio. We do not want concentration into one specific area from several portfolio companies. I.e. we shouldn’t have multiple biotechs targeting the same indication with too similar of methods of action. Given we are an early investor, 90%+ of our investments will need significant additional capital before they reach our required exit valuation. Our founders and investments need the ability to recruit additional resources - capital, talent and other forms of support - to reach that exit. We help teach some of this, but our founders must be able to adapt and learn the skill. An ideal investment gives us the opportunity to return a significant portion of the fund (over 50%) between years 7-10, with a goal of reaching 1x DPI by year 7/8. Sometimes this will happen through secondary sales (full or partial) that help secure returns for our LPs while maximizing the opportunity for a 10x+ fund.

Locations

4215 E Stevens Way NE, 431, Seattle, WA 98195 HQ
location_iconSOSV/IndieBio - 2565 3rd St Ste 318, San Francisco, CA 94107
Reply Rate

20%

Responds in

13 hours

Pack Ventures Team

Ken Horenstein

Ken Horenstein

GP/MD

Pack Ventures Portfolio

Supio

Supio

supio.com

Turion Space

Turion Space

turionspace.com

Founder Reviews Of Pack Ventures

No reviews yet

Write The First Review

Similar Investors

Euclid Ventures verified_icon

VC firm

Countries of investment

Flag of Canada CanadaFlag of USA USA

Cervin Ventures verified_icon

VC firm

Countries of investment

Flag of USA USAFlag of Israel Israel

Ganas Ventures verified_icon

VC firm

Countries of investment

Flag of Argentina ArgentinaFlag of Belize Belize+22

Empath Ventures

VC firm

Countries of investment

Flag of Australia AustraliaFlag of UK UK+1

Pace Ventures verified_icon

VC firm

Countries of investment

Flag of USA USAFlag of UK UK+2

Countries of investment

Flag of Canada CanadaFlag of USA USA
Your Fundraising Powerhouse

OpenVC has more than 10,000 investor profiles like this one.

Discover how each investor thinks, what they fund, and whether they’re the right fit for your startup.

loggedout_cta
Loading, please wait...

Are you sure you want to contact this investor ?

Pick the best recipient for your submission

Default Email

The default email for cold outreach

Send your email

You need to be logged in as a founder to submit your deck to investors.
Sign up or log in now
Copy subject

Please avoid terms like "pitch", "deck", "intro" or "opportunity" in the email subject.

Please remove quotation marks from the start and/or the end of the email subject.

Please don't use full CAPS in the email subject.

Please do not insert an email address in the email subject.

Please do not use "!!" or "??" in the email subject.

Copy message
- OR -

Start your email with a personal greeting eg. "Hi John," or "Hello XXX Team,".

Please don't include URLs in your email body to maximize reply rate. We already link to your pitch deck and calendar automatically.

Make sure to include numbers (growth, revenue, etc.) in your email to capture attention.

Write shorter paragraphs to improve readibility. You can also use bulletpoints if you need to list down information.

No need to mention OpenVC in your email. Focus the conversation on your business.

Pitch deck

Choose your pitch deck below:

You need to sign up to upload your deck to OpenVC.
Create an account, it's 100% free !

Please provide a direct link to the pitch deck - not to a folder

Don't share a read-only Google Slides, it may be poorly perceived by some investors. Instead, host a PDF on DocSend or Google Drive and share that link.

Your link doesn't work. We recommend hosting your pitch deck as a PDF on Google Drive, Dropbox, DocSend, etc.

You need to be logged in as a founder to submit your deck to investors.
Sign up or log in now